Evidence map›Paper›PMID 30793400›Full record

ArticleProtein science : a publication of the Protein Society2019

Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif.

Noah Manczyk, Gianluca Veggiani, Gerald D Gish, Bradley P Yates, Andreas Ernst, Sachdev S Sidhu, Frank Sicheri

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Inhibiting Infectious Bronchitis Virus PLpro Using Ubiquitin Variants.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Noah ManczykLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Gianluca VeggianiDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Gerald D GishLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
Bradley P YatesDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Andreas ErnstInstitute of Biochemistry II, Goethe University, Frankfurt am Main 60590, Germany.
Sachdev S SidhuDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Frank SicheriLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
University of Toronto · CAMount Sinai Hospital · CAGoethe University Frankfurt · DE

Funding

CIHR FDN143277CIHR MOP-136956
6 · The paper itself

Abstract

We previously described structural and functional characterization of the first ubiquitin variant (UbV), UbV.v27.1, engineered by phage display to bind with high affinity to a specific ubiquitin interacting motif (UIM). We identified two substitutions relative to ubiquitin (Gly10Val/His68Tyr) that were critical for enhancing binding affinity but could only rationalize the mechanism of action of the Tyr68 substitution. Here, we extend our characterization and uncover the mechanism by which the Val10 substitution enhances binding affinity. We show that Val10 in UbV.v27.1 drives UbV dimerization through an intermolecular β-strand exchange. Dimerization serves to increase the contact surface between the UIM and UbV and also affords direct contacts between two UIMs through an overall 2:2 binding stoichiometry. Our identification of the role of Val10 in UbV dimerization suggests a general means for the development of dimeric UbVs with improved affinity and specificity relative to their monomeric UbV counterparts. Statement: Previously, we used phage display to engineer a UbV that bound tightly and specifically to a UIM. Here, we discovered that tight binding is partly due to the dimerization of the UbV, which increases the contact surface between the UbV and UIM. We show that UbV dimerization is dependent on the Gly10Val substitution, and posit that dimerization may provide a general means for engineering UbVs with improved binding properties.

Indexed as

Amino Acid SubstitutionBinding SitesCell Surface Display TechniquesHumansModels, MolecularProtein BindingProtein EngineeringProtein MultimerizationProtein Structure, SecondaryUbiquitinValineUbiquitinValinedimerphage displayprotein engineeringubiquitinubiquitin interacting motif

Identifiers

PMID30793400
PMCPMC6459996
OpenAlexW2920147490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.